This Company has developed a Personalized App to Fight Cancer

Screen Shot 2016 11 03 at 17.02.21

We say goodbye to the good weather in Spain and cross the Pyrenees to visit Charleroi, an industrial city south of Brussels. There, we find OncoDNA, a young company striving to change the oncology field using DNA.

OncoDNA logo

City: Charleroi, Belgium

Founded: 2012

Employees: 11 – 50

Financial data: €7.7M raised in September to expand into the global market

OncoDNA CEO Jean-Pol Detiffe
Jean-Pol Detiffe, CEO

Mission: OncoDNA uses next-generation sequencing to analyze major DNA mutations in cancer and match the patient with a personalized treatment option. The coolest part is that the whole process can be controlled via a mobile app with a pretty neat design. On April, the company launched OncoTRACE, the first non-invasive personalized test to monitor tumor progression.

Comment: OncoDNA could pass for the smaller sibling of Foundation Medicine in the US. Jean-Pol Detiffe, its CEO, will be speaking at Labiotech Refresh this November. Don’t miss it!


Newsletter Signup - Under Article / In Page

"*" indicates required fields

Subscribe to our newsletter to get the latest biotech news!

This field is for validation purposes and should be left unchanged.

Suggested Articles

Show More